Novel mechanisms and clinical trial endpoints in intestinal fibrosis*
2021 · Immunological Reviews · 105 citations
https://doi.org/10.1111/imr.12974
J
Jie Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
2.4K
Citations
25
h-index
42
i10-index
Jie Wang is an academic researcher from Tongji University. The author has contributed to research in topics: interferon and immune responses & Inflammatory Bowel Disease & Viral Infections and Vectors. The author has an h-index of 25, co-authored 69 publications.
ORCID: 0000-0003-4495-8862Papers by this author
worksStricturing Crohn’s Disease Single-Cell RNA Sequencing Reveals Fibroblast Heterogeneity and Intercellular Interactions
2023 · Gastroenterology · 86 citations
https://doi.org/10.1053/j.gastro.2023.07.014
Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases
2021 · Physiological Reviews · 68 citations
https://doi.org/10.1152/physrev.00005.2021
Milk fat globule-epidermal growth factor 8 (MFGE8) prevents intestinal fibrosis
2024 · Gut · 23 citations
https://doi.org/10.1136/gutjnl-2022-328608
Effect of Body Weight on Risk‐Benefit and Dosing Regimen Recommendation of Secukinumab for the Treatment of Moderate to Severe Plaque Psoriasis
2019 · Clinical Pharmacology & Therapeutics · 13 citations
https://doi.org/10.1002/cpt.1478
S-nitrosothiol homeostasis maintained by ADH5 facilitates STING-dependent host defense against pathogens
2024 · Nature Communications · 12 citations
https://doi.org/10.1038/s41467-024-46212-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat